AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Egybort 3.5mg Injection

Prescription Icon
Prescription Required

Marketer

United Biotech Pvt Ltd

Salt Composition

Bortezomib (3.5mg)

Overview Egybort 3.5mg Injection

Borneal 3.5mg Injection treats multiple myeloma and mantle cell lymphoma by inhibiting or decelerating cancerous cell proliferation. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your condition and may vary. Strictly adhere to your doctor's instructions; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects may take weeks or months to manifest; discontinue only under medical supervision. Common side effects include tiredness, nausea, vomiting, and decreased appetite. Increased fluid intake is often recommended. Drowsiness and dizziness may impair driving and operating machinery. This medication can lower blood cell counts (red and white), increasing infection risk. Regular blood tests monitoring blood cell levels, along with heart, liver function, and uric acid levels, are necessary. Prior to commencing treatment, disclose any liver, kidney, heart conditions, or bleeding disorders to your doctor. Report cognitive symptoms such as memory impairment or difficulty concentrating. Inform your healthcare provider of all other medications you are taking, as interactions are possible. This injection is contraindicated during pregnancy and breastfeeding; reliable contraception is essential for both partners throughout treatment.

Uses of Egybort 3.5mg Injection

Myeloma and mantle cell lymphoma

Major Benefits of Egybort 3.5mg Injection:

Administering this medication will be done by your physician or their designated nurse; self-medication is strictly prohibited.

Common Side effects of Egybort 3.5mg Injection:

  • Low blood platelets
  • Fatigue
  • Peripheral neuropathy (tingling and numbness of feet and hand)
  • Psychiatric disturbances
  • Nausea
  • Vomiting
  • Loss of appetite
  • Fever
  • Anemia (low number of red blood cells)
  • Diarrhea
  • Decreased appetite
  • Decreased white blood cell count (neutrophils)
  • Constipation

How to use Egybort 3.5mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Egybort 3.5mg Injection works:

Egybort 3.5mg Injection is an anticancer drug that inhibits protein degradation within cells. This accumulation of intracellular proteins triggers apoptosis in cancerous cells.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concomitant use of Egybort 3.5mg Injection and alcohol may induce significant somnolence.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Egybort 3.5mg Injection during pregnancy is contraindicated due to established risks to fetal development. Exceptions may exist in critical circumstances where a physician deems the potential benefits outweigh the hazards. Physician consultation is mandatory.

Breast feedingBreast feedingUNSAFE

Administration of Egybort 3.5mg Injection is contraindicated while breastfeeding due to potential infant toxicity. Studies indicate a risk of harmful effects to the nursing infant.

DrivingDrivingUNSAFE

The administration of Egybort 3.5mg Injection may induce adverse reactions that could impair driving capabilities. These potential effects include drowsiness, vertigo, syncope, or visual disturbances, all of which might negatively impact the ability to operate a vehicle.

KidneyKidneyCAUTION

For individuals with severe kidney impairment, the administration of Egybort 3.5mg Injection requires careful monitoring. Dosage modification of Egybort 3.5mg Injection might be necessary. Physician consultation is recommended.

LiverLiverCAUTION

The use of Egybort 3.5mg Injection requires careful consideration in individuals with hepatic impairment. Dosage modification of Egybort 3.5mg Injection might be necessary. Physician consultation is recommended.

What if you forget to take Egybort 3.5mg Injection :

Omitting a scheduled dose of Egybort 3.5mg Injection warrants immediate physician consultation.

Facts to Know About Egybort 3.5mg Injection

LabelValue
Chemical Category Phenylalanine-based Compounds
Developing Habits No.
Treatment Category Cancer Medications

FAQs on Egybort 3.5mg Injection

Seek immediate medical attention for muscle cramps, weakness, confusion, vision problems (including blindness), seizures, headaches, shortness of breath, swollen feet, irregular heartbeat, high blood pressure, fatigue, fainting, coughing, breathing difficulties, or chest tightness.
Continue this medication precisely as prescribed until your physician instructs otherwise. Tumor response will be monitored through regular scans, scheduled at your doctor's discretion.
Egybort 3.5mg Injection reduces white blood cells and platelets, increasing infection and bleeding risks. Avoid contact with sick individuals. Report any infection symptoms (fever, chills, cough) or bleeding to your doctor promptly. Use caution with sharp objects and a soft-bristled toothbrush to minimize bleeding.
This medication is contraindicated during pregnancy due to the risk of harm to the developing fetus. Avoid pregnancy, using reliable contraception throughout treatment and for three months following your final dose of Egybort 3.5mg Injection.
This medication carries a risk of serious, potentially fatal lung problems. Seek immediate medical attention if you experience severe shortness of breath, confusion, a dry cough, dizziness, or overwhelming fatigue.
This medication may cause hair brittleness, breakage, patchy loss, or thinning. These side effects usually disappear after you stop taking the medicine. Handle your hair gently when washing and brushing to minimize shedding.
This medication may cause tingling, numbness, pain, or burning in your arms or legs. Reduced sensation can impair balance and coordination, increasing your fall risk. Report these symptoms to your doctor; your dosage or treatment schedule may require adjustment.
Soothe rashes and dry, itchy skin with a moisturizer. Protect your skin from the sun by wearing protective clothing and sunscreen (SPF 15+) outdoors. Avoid swimming while experiencing a rash, as chlorine can aggravate it. Opt for lukewarm baths and loose-fitting cotton clothing. Skin typically improves after treatment ends.
Ease constipation by eating plenty of fiber-rich fruits and vegetables, drinking 8–10 glasses of water daily, and staying active. A doctor-prescribed stool softener, taken once or twice a day, can help prevent constipation. Consult your doctor if you haven't had a bowel movement in 2–3 days.
This medication may cause nausea and fatigue. To alleviate nausea, try eating smaller, more frequent meals and avoid salty, spicy, fatty, or fried foods. Combat fatigue with adequate rest and light daily exercise.
Changes in taste are common during cancer treatment; you might notice a metallic taste, lack of taste, or a dislike for previously enjoyed foods and drinks. To alleviate this, try rinsing your mouth with a salt and bicarbonate of soda solution before meals. Adding extra flavorings to your food can also help.
Egybort 3.5mg Injection
13,500